UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.423

Sortiert nach

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial

Annals of oncology, 2015-12, Vol.26 (12), p.2429-2436

2015

Link zum Volltext

Verfügbarkeit prüfen

A global meta-analysis of the economic values of provisioning and cultural ecosystem services

The Science of the total environment, 2019-02, Vol.649, p.1293-1298

2019

Link zum Volltext

Verfügbarkeit prüfen

Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer

JNCI : Journal of the National Cancer Institute, 2004-05, Vol.96 (10), p.759-769

2004

Link zum Volltext

Verfügbarkeit prüfen

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Annals of oncology, 2009-09, Vol.20 (9), p.1489-1498

2009

Link zum Volltext

Verfügbarkeit prüfen

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Annals of oncology, 2011-03, Vol.22 (3), p.595-602

2011

Link zum Volltext

Verfügbarkeit prüfen

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

British journal of cancer, 2014-11, Vol.111 (11), p.2051-2057

2014

Link zum Volltext

Verfügbarkeit prüfen

ONCOPOOL – A European database for 16,944 cases of breast cancer

European journal of cancer (1990), 2010-01, Vol.46 (1), p.56-71

2010

Link zum Volltext

Verfügbarkeit prüfen

E08. Highlights in benign and pre-invasive breast disease

European journal of cancer (1990), 2014-03, Vol.50, p.S15-S16

2014

Link zum Volltext

Verfügbarkeit prüfen

1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S263-S264

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomised, phase II trial comparing oral capecitabine (Xeloda ) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

British journal of cancer, 2002-05, Vol.86 (9), p.1367-1372

2002

Link zum Volltext

Verfügbarkeit prüfen

50 Long Term Results and Prognostic Factors in Patients with Unicentric and Multicentric Breast Cancer

European journal of cancer (1990), 2012-03, Vol.48, p.S55-S55

2012

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab treatment in patients with breast cancer and metastatic CNS disease

Annals of oncology, 2010-05, Vol.21 (5), p.917-924

2010

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant

Breast cancer research and treatment, 2005-07, Vol.92 (2), p.169-174

2005

Link zum Volltext

Verfügbarkeit prüfen

5130 POSTER Long Term Results and Prognostic Factors in Patients With Unicentric and Multicentric Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S369-S369

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

Annals of oncology, 2016-06, Vol.27 (6), p.1041-1047

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71]

European journal of cancer (1990), 2010-06, Vol.46 (9), p.1762-1762

2010

Link zum Volltext

Verfügbarkeit prüfen

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5960-5972

2005

Link zum Volltext

Verfügbarkeit prüfen

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer : a phase I study

Cancer chemotherapy and pharmacology, 2007-06, Vol.59 (6), p.703-709

2007

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1707-1715

2001

Link zum Volltext

Verfügbarkeit prüfen

P301 Addition of pertuzumab (P) to trastuzumab (H)-based neoadjuvant chemotherapy significantly improves pathological complete response in women with HER2-positive early breast cancer: Result of a randomised phase II study (NEOSPHERE)

Breast (Edinburgh), 2011, Vol.20, p.S73-S73

2011

Link zum Volltext

Verfügbarkeit prüfen

Processes Induced by Tau Expression in Sf9 Cells Have an Axon-like Microtubule Organization

The Journal of cell biology, 1991-12, Vol.115 (5), p.1333-1344

1991

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Docetaxel for Node-Positive Breast Cancer

The New England journal of medicine, 2005-06, Vol.352 (22), p.2302-2313

2005

Link zum Volltext

Verfügbarkeit prüfen

Sites of microtubule stabilization for the axon

The Journal of neuroscience, 1993-05, Vol.13 (5), p.2177-2185

1993

Link zum Volltext

Verfügbarkeit prüfen

131P Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer

Annals of oncology, 2021-09, Vol.32, p.S415-S416

2021

Link zum Volltext

Verfügbarkeit prüfen

Survival of HER2-positive advanced breast cancer patients treated with lapatinib plus capecitabine: A national population-based study: Long-term analysis

Annals of oncology, 2018-10, Vol.29, p.viii105-viii105

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.162)
Mit Volltextzugriff
(1.237)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.197)
Französisch
(171)
Japanisch
(94)
Polnisch
(64)
Russisch
(9)
Deutsch
(4)
Norwegisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(610)
Life Sciences & Biomedicine
(465)
Humans
(338)
Female
(259)
Biological And Medical Sciences
(153)
Male
(149)
Adult
(133)
Oncology
(130)
Middle Aged
(125)
Physical Sciences
(107)
Medical Sciences
(101)
Aged
(98)
Animals
(87)
Physics
(84)
Adolescent
(73)
Child
(68)
Fundamental And Applied Biological Sciences. Psychology
(67)
Breast Neoplasms - Drug Therapy
(55)
Treatment Outcome
(50)
Endocrinology & Metabolism
(49)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial

A global meta-analysis of the economic values of provisioning and cultural ecosystem services

Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

ONCOPOOL – A European database for 16,944 cases of breast cancer

E08. Highlights in benign and pre-invasive breast disease

1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

Randomised, phase II trial comparing oral capecitabine (Xeloda ) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

50 Long Term Results and Prognostic Factors in Patients with Unicentric and Multicentric Breast Cancer

Trastuzumab treatment in patients with breast cancer and metastatic CNS disease

Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant

5130 POSTER Long Term Results and Prognostic Factors in Patients With Unicentric and Multicentric Breast Cancer

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71]

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer : a phase I study

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

P301 Addition of pertuzumab (P) to trastuzumab (H)-based neoadjuvant chemotherapy significantly improves pathological complete response in women with HER2-positive early breast cancer: Result of a randomised phase II study (NEOSPHERE)

Processes Induced by Tau Expression in Sf9 Cells Have an Axon-like Microtubule Organization

Adjuvant Docetaxel for Node-Positive Breast Cancer

Sites of microtubule stabilization for the axon

131P Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer

Survival of HER2-positive advanced breast cancer patients treated with lapatinib plus capecitabine: A national population-based study: Long-term analysis

Suchergebnisse filtern